Compliance SweepBack to stories →
← Back to stories
Governance & business operationsNew in this edition

FDA finalizes guidance on validating diagnostic tests for emerging pathogens during a declared emergency

The Food and Drug Administration (FDA) announced on November 10, 2026 a final guidance, Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency. It gives general recommendations for validating in vitro diagnostic devices (IVDs) for emerging pathogens during an applicable declaration of public health emergency (PHE), with a template, and applies to data submitted in a pre-Emergency Use Authorization (EUA) request, an EUA request, or for a test offered under an applicable enforcement discretion policy. The guidance is not binding.

Background

FDA issued the draft guidance in January 2025 (90 FR 1168). The guidance answers recommendations from an October 2021 independent assessment and a September 2022 HHS Office of Inspector General (OIG) report on FDA's COVID-19 testing response.

Who this affects

Hospital and health-system clinical laboratories that develop or validate their own tests during outbreaks.

Why it matters

Inference: hospital laboratories that would bring up their own tests in a future outbreak now have FDA's stated validation expectations in advance, which can shorten an emergency submission.

Scope and timing

Authority status
Guidance
Responsible owner
Laboratory
Publication date
2026-11-10
Other dates
Comments on guidance accepted at any time; draft guidance noticed 2025-01-07 (90 FR 1168)

Not established

The guidance document itself was not read; this entry rests on the Federal Register notice of availability.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies